INS and Hyperglycemia: For noncritical ill diabetic inpatients, they suggested the use of specific insulin regimens with combined basal and short-acting insulin and appropriate bedside glucose monitoring, avoiding the use of sliding-scale insulin (fast or rapid-acting insulin in response to hyperglycemia) alone.